Intercept Pharmaceuticals | Marktkapitalisierung



Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 3.6B 10M 2025-09
Alnylam Pharmaceuticals USD 39.74B 12.8B 2026-02
Amarin USD 341M 4M 2025-09
Amgen USD 201.45B 25.2B 2026-02
Arrowhead Research USD 8.04B 973M 2026-02
AstraZeneca USD 222.33B 65.82B 2026-02
Biogen USD 27.01B 1.19B 2026-02
Bristol-Myers Squibb USD 123.58B 13.77B 2026-02
Eli Lilly USD 1.01T 3.37B 2026-02
Enanta Pharmaceuticals USD 198M 37M 2023-12
Esperion Therapeutics USD 340M 235M 2023-12
Galectin Therapeutics USD 103M 11M 2023-12
Gilead Sciences USD 183.59B 31.31B 2026-02
GlaxoSmithKline GBP 87.33B 12.98B 2026-02
Incyte USD 22.7B 3.31B 2026-02
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
Moderna USD 16.5B 6.41B 2026-02
Neurocrine Biosciences USD 13.68B 465M 2026-02
Novartis USD 265.66B 9.48B 2025-09
PTC Therapeutics USD 5.36B 744M 2026-02
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.02B 336M 2025-09
Vertex Pharmaceuticals USD 120.12B 5.09B 2026-02


Intercept Pharmaceuticals Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.